Unknown

Dataset Information

0

Chimeric Antigen Receptor Library Screening Using a Novel NF-?B/NFAT Reporter Cell Platform.


ABSTRACT: Chimeric antigen receptor (CAR)-T cell immunotherapy is under intense preclinical and clinical investigation, and it involves a rapidly increasing portfolio of novel target antigens and CAR designs. We established a platform that enables rapid and high-throughput CAR-screening campaigns with reporter cells derived from the T cell lymphoma line Jurkat. Reporter cells were equipped with nuclear factor ?B (NF-?B) and nuclear factor of activated T cells (NFAT) reporter genes that generate a duplex output of enhanced CFP (ECFP) and EGFP, respectively. As a proof of concept, we modified reporter cells with CD19-specific and ROR1-specific CARs, and we detected high-level reporter signals that allowed distinguishing functional from non-functional CAR constructs. The reporter data were highly reproducible, and the time required for completing each testing campaign was substantially shorter with reporter cells (6 days) compared to primary CAR-T cells (21 days). We challenged the reporter platform to a large-scale screening campaign on a ROR1-CAR library, and we showed that reporter cells retrieved a functional CAR variant that was present with a frequency of only 6 in 1.05 × 106. The data illustrate the potential to implement this reporter platform into the preclinical development path of novel CAR-T cell products and to inform and accelerate the selection of lead CAR candidates for clinical translation.

SUBMITTER: Rydzek J 

PROVIDER: S-EPMC6369451 | biostudies-literature | 2019 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.

Rydzek Julian J   Nerreter Thomas T   Peng Haiyong H   Jutz Sabrina S   Leitner Judith J   Steinberger Peter P   Einsele Hermann H   Rader Christoph C   Hudecek Michael M  

Molecular therapy : the journal of the American Society of Gene Therapy 20181120 2


Chimeric antigen receptor (CAR)-T cell immunotherapy is under intense preclinical and clinical investigation, and it involves a rapidly increasing portfolio of novel target antigens and CAR designs. We established a platform that enables rapid and high-throughput CAR-screening campaigns with reporter cells derived from the T cell lymphoma line Jurkat. Reporter cells were equipped with nuclear factor κB (NF-κB) and nuclear factor of activated T cells (NFAT) reporter genes that generate a duplex o  ...[more]

Similar Datasets

2021-07-13 | GSE179767 | GEO
| S-EPMC7458653 | biostudies-literature
| S-EPMC4661856 | biostudies-literature
| S-EPMC9280998 | biostudies-literature
| S-EPMC10457194 | biostudies-literature
| S-EPMC5665068 | biostudies-literature
| S-EPMC5865610 | biostudies-literature
| S-EPMC11307286 | biostudies-literature
| S-EPMC4720301 | biostudies-literature
| S-EPMC9981691 | biostudies-literature